SCHEMBL31723401

SCHEMBL31723401

CC(C)c1cccc(C(C)C)c1Nc1cccc(Br)c1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.38
CXCL8 P10145 3/20 0.36
LPAR1 Q92633 2/20 0.35
LMNA P02545 2/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NLRP3 Q96P20 1/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
FAAH O00519 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GABRA1 P14867 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
PTGS1 P23219 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4131377 0.84 CXCR2 (0.45) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
SCHEMBL31723956 0.78 LPAR1 (0.34) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
SCHEMBL6744857 0.78 LMNA (0.47) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
SCHEMBL31447156 0.78 LMNA (0.47) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
SCHEMBL11421517 0.78 GABRA1 (0.44) LMNACA1CA2FAAHCYP1A2
SCHEMBL30299532 0.77 MAPT (0.47) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
SCHEMBL2458400 0.77 MAPT (0.47) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL31043542 0.76 MAPT (0.46) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
SCHEMBL31723403 0.74 GAA (0.38) CXCL8LPAR1LMNAKMT2ASMN1; SMN2
SCHEMBL812723 0.73 GABRA1 (0.52) LPAR1LMNAKMT2ASMN1; SMN2NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250351719-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2025-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250351719-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, PDCD2L EGFR 778/4885CXCL8 1961/4885LPAR1 2835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.